These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 26032770)

  • 1. Cas9-chromatin binding information enables more accurate CRISPR off-target prediction.
    Singh R; Kuscu C; Quinlan A; Qi Y; Adli M
    Nucleic Acids Res; 2015 Oct; 43(18):e118. PubMed ID: 26032770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases.
    Zhu LJ; Lawrence M; Gupta A; Pagès H; Kucukural A; Garber M; Wolfe SA
    BMC Genomics; 2017 May; 18(1):379. PubMed ID: 28506212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences.
    Lin Y; Cradick TJ; Brown MT; Deshmukh H; Ranjan P; Sarode N; Wile BM; Vertino PM; Stewart FJ; Bao G
    Nucleic Acids Res; 2014 Jun; 42(11):7473-85. PubMed ID: 24838573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas mutagenesis of soybean and Medicago truncatula using a new web-tool and a modified Cas9 enzyme.
    Michno JM; Wang X; Liu J; Curtin SJ; Kono TJ; Stupar RM
    GM Crops Food; 2015; 6(4):243-52. PubMed ID: 26479970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool.
    Stemmer M; Thumberger T; Del Sol Keyer M; Wittbrodt J; Mateo JL
    PLoS One; 2015; 10(4):e0124633. PubMed ID: 25909470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WU-CRISPR: characteristics of functional guide RNAs for the CRISPR/Cas9 system.
    Wong N; Liu W; Wang X
    Genome Biol; 2015 Nov; 16():218. PubMed ID: 26521937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PhytoCRISP-Ex: a web-based and stand-alone application to find specific target sequences for CRISPR/CAS editing.
    Rastogi A; Murik O; Bowler C; Tirichine L
    BMC Bioinformatics; 2016 Jul; 17(1):261. PubMed ID: 27363443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of CRISPR-Cas9 genome interrogation in living cells.
    Knight SC; Xie L; Deng W; Guglielmi B; Witkowsky LB; Bosanac L; Zhang ET; El Beheiry M; Masson JB; Dahan M; Liu Z; Doudna JA; Tjian R
    Science; 2015 Nov; 350(6262):823-6. PubMed ID: 26564855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage.
    Josephs EA; Kocak DD; Fitzgibbon CJ; McMenemy J; Gersbach CA; Marszalek PE
    Nucleic Acids Res; 2015 Oct; 43(18):8924-41. PubMed ID: 26384421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering.
    Nuñez JK; Harrington LB; Doudna JA
    ACS Chem Biol; 2016 Mar; 11(3):681-8. PubMed ID: 26857072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency and Inheritance of Targeted Mutagenesis in Maize Using CRISPR-Cas9.
    Zhu J; Song N; Sun S; Yang W; Zhao H; Song W; Lai J
    J Genet Genomics; 2016 Jan; 43(1):25-36. PubMed ID: 26842991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research.
    Fujita T; Fujii H
    Int J Mol Sci; 2015 Sep; 16(10):23143-64. PubMed ID: 26404236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome engineering using CRISPR-Cas9 system.
    Cong L; Zhang F
    Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Guide to Computational Tools and Design Strategies for Genome Editing Experiments in Zebrafish Using CRISPR/Cas9.
    Prykhozhij SV; Rajan V; Berman JN
    Zebrafish; 2016 Feb; 13(1):70-3. PubMed ID: 26683213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.
    Pattanayak V; Guilinger JP; Liu DR
    Methods Enzymol; 2014; 546():47-78. PubMed ID: 25398335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells.
    Moore R; Spinhirne A; Lai MJ; Preisser S; Li Y; Kang T; Bleris L
    Nucleic Acids Res; 2015 Jan; 43(2):1297-303. PubMed ID: 25527740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleosomes Inhibit Cas9 Endonuclease Activity in Vitro.
    Hinz JM; Laughery MF; Wyrick JJ
    Biochemistry; 2015 Dec; 54(48):7063-6. PubMed ID: 26579937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.